Gf Fund Management Co. Ltd. Vaxcyte, Inc. Transaction History
Gf Fund Management Co. Ltd.
- $4.26 Trillion
- Q1 2025
A detailed history of Gf Fund Management Co. Ltd. transactions in Vaxcyte, Inc. stock. As of the latest transaction made, Gf Fund Management Co. Ltd. holds 3,192 shares of PCVX stock, worth $104,921. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,192
Previous 2,617
21.97%
Holding current value
$104,921
Previous $214 Million
43.74%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding PCVX
# of Institutions
345Shares Held
136MCall Options Held
348KPut Options Held
250K-
Ra Capital Management, L.P. Boston, MA12.2MShares$401 Million9.56% of portfolio
-
Vanguard Group Inc Valley Forge, PA12MShares$396 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X011.8MShares$387 Million0.25% of portfolio
-
Black Rock Inc. New York, NY9.94MShares$327 Million0.02% of portfolio
-
Wellington Management Group LLP Boston, MA6.42MShares$211 Million0.05% of portfolio
About Vaxcyte, Inc.
- Ticker PCVX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,315,100
- Market Cap $1.95B
- Description
- Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine that is in Phase 1/2 clinical trials to treat invasive pneumococcal disease and pneumonia. The company a...